ALLOPURINOL MODULATION OF HIGH-DOSE FLUOROURACIL TOXICITY

被引：36

作者：

FOX, RM ^{[1
]}

WOODS, RL ^{[1
]}

TATTERSALL, MHN ^{[1
]}

BRODIE, GW ^{[1
]}

机构：

[1] PRINCE HENRYS HOSP,DEPT MED ONCOL,MELBOURNE 3004,VICTORIA,AUSTRALIA

来源：

CANCER TREATMENT REVIEWS | 1979年 / 6卷

关键词：

D O I：

10.1016/S0305-7372(79)80034-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：143 / 147

页数：5

共 9 条

[1] RENAL CLEARANCE OF OXIPURINOL CHIEF METABOLITE OF ALLOPURINOL [J].

ELION, GB ;

YU, TF ;

GUTMAN, AB ;

HITCHINGS, GH .

AMERICAN JOURNAL OF MEDICINE, 1968, 45 (01) :69-+

[2] STUDIES ON COORDINATE ACTIVITY AND LABILITY OF OROTIDYLATE PHOSPHORIBOSYLTRANSFERASE AND DECARBOXYLASE IN HUMAN ERYTHROCYTES, AND EFFECTS OF ALLOPURINOL ADMINISTRATION [J].

FOX, RM ;

WOOD, MH ;

OSULLIVA.WJ .

JOURNAL OF CLINICAL INVESTIGATION, 1971, 50 (05) :1050-&

[3] OROTIDINURIA INDUCED BY ALLOPURINOL [J].

FOX, RM ;

ROYSESMI.D ;

OSULLIVA.WJ .

SCIENCE, 1970, 168 (3933) :861-&

[4]

HEIDELBERGER C, 1975, HDB EXPT PHARM ANTIN, P193

[5]

MOERTEL CG, 1967, SURG CLIN N AM, V47, P929

[6]

MOERTEL CG, 1978, NEW ENGL J MED, V299, P1048

[7]

SCHWARTZ PM, 1978, P AM ASSOC CANC RES, V19, P111

[8]

SEIFERT P, 1975, CANCER-AM CANCER SOC, V36, P123, DOI 10.1002/1097-0142(197507)36:1<123::AID-CNCR2820360108>3.0.CO

[9]

2-C

← 1 →